| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/27/2006 | CN1839153A Oxidoreductase from pichia capsulata |
| 09/27/2006 | CN1839144A Methods for humanizing rabbit monoclonal antibodies |
| 09/27/2006 | CN1838968A Antibodies aimed to parathyroid hormone (PTH) and uses thereof |
| 09/27/2006 | CN1837360A Prostaglandin reductase |
| 09/27/2006 | CN1837238A Monoclonal antibody against MBL and its use |
| 09/27/2006 | CN1837233A Halophilic bacteria and its immune protein and genes encoding same and use thereof |
| 09/27/2006 | CN1276975C Recombinant protein containing C-terminal fragment of plasmodium MSP-1 |
| 09/26/2006 | US7112667 Sequences of an Ih ion channel and use thereof |
| 09/26/2006 | US7112666 Von Willebrand Factor (Vwf)-cleaving protease |
| 09/26/2006 | US7112664 Hepatitis B virus (HBV); cDNA encoding said variable region; vectors and transformed cells; use to develop monoclonal antibodies for immunotherapy or diagnosis; A transformant E. coli DH5 alpha /YRC-pCRA9Hv; |
| 09/26/2006 | US7112662 Anti-metasin antibodies and their methods of use |
| 09/26/2006 | US7112661 Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein Ib alpha |
| 09/26/2006 | US7112659 Given DNA sequence; Fc immunoglobulin region attached; transforming cell; use in treating obesity; isolated human leptin fusion protein; for treating excess weight in an individual or animals, including modulation of and/or fat deposition |
| 09/26/2006 | US7112657 PRO polypeptides; fusion proteins; immunoglobulins |
| 09/26/2006 | US7112562 Insulin conjugates and methods of use thereof |
| 09/26/2006 | US7112439 Dual expression vector system for antibody expression in bacterial and mammalian cells |
| 09/26/2006 | US7112430 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon |
| 09/26/2006 | US7112427 Protein comprising mitogenic kinase activity for identifying modulators of inflammation, apoptosis and cell proliferation; antiproliferative agents |
| 09/26/2006 | US7112426 Human cAMP-dependent protein kinase beta-catalytic subunit |
| 09/26/2006 | US7112421 Nucleic acids encoding BAFF receptor, chimeric proteins and methods and compositions related thereto |
| 09/26/2006 | US7112418 Ion channel |
| 09/26/2006 | US7112414 Masp-2, a complement-fixing enzyme, and uses for it |
| 09/26/2006 | US7112412 Binding to prostate specific membrane antigen (PSMA) with a radioactive monoclonal antibody or Fab fragments; detecting and kill the cancer cells; bioassay; radiotherapy |
| 09/26/2006 | US7112327 Inhibition of complement activation |
| 09/26/2006 | US7112324 CD 19×CD3 specific polypeptides and uses thereof |
| 09/26/2006 | US7112317 Administering a targeting agent operatively attached to a therapeutic agent; the targeting agent recognizes and binds to a tumor-associated endothelial cell marker. |
| 09/26/2006 | CA2345903C Molecular pathogenicide mediated plant disease resistance |
| 09/26/2006 | CA2283464C Functional dna clone for hepatitis c virus (hcv) and uses thereof |
| 09/21/2006 | WO2006099481A2 Macromolecules comprising a thioether cross-link |
| 09/21/2006 | WO2006099480A2 Stress proteins and peptides and methods of use thereof |
| 09/21/2006 | WO2006098987A2 Methods of inhibiting angiogenesis and tumor development |
| 09/21/2006 | WO2006098607A1 Histamine-containing composition for the treatment of allergic diseases |
| 09/21/2006 | WO2006098465A1 Prophylactic/therapeutic agent for cancer |
| 09/21/2006 | WO2006098464A1 Method for diagnosis of prostate cancer |
| 09/21/2006 | WO2006098304A1 Novel secretory protein derived from pituitary cell and use of the same |
| 09/21/2006 | WO2006098144A1 Detection marker, detection kit and detection method for idiopathic pulmonary fibrosis |
| 09/21/2006 | WO2006097689A2 Antibodies against candida antigens |
| 09/21/2006 | WO2006097335A1 A new element of the wg/wnt signaling pathway |
| 09/21/2006 | WO2006063462A9 Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
| 09/21/2006 | WO2006058300A3 Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (pth) 1-84 |
| 09/21/2006 | WO2006042240A3 Immunotherapy of autoimmune disorders |
| 09/21/2006 | WO2006033700A3 Her2 antibody composition |
| 09/21/2006 | WO2006023651A3 Extended treatment of multiple sclerosis |
| 09/21/2006 | WO2005067620A8 ANTIBODIES TO MAdCAM |
| 09/21/2006 | WO2005058236A8 Cab molecules |
| 09/21/2006 | WO2005026321A3 Protein o-sulfonation |
| 09/21/2006 | WO2002050303A3 Protein-protein interactions |
| 09/21/2006 | US20060211622 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof |
| 09/21/2006 | US20060211619 Polypeptide having endopeptidase domain;translocation domain having more than one binding domain directed to a cell surface feature of a target cell; modified neurotoxins; to prevent exocytosis and secretion by the target cell; disorders of tsensory or motor nervous system, acute or chronic pain, cancer |
| 09/21/2006 | US20060211601 Nitrosated and nitrosylated heme proteins |
| 09/21/2006 | US20060211150 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211149 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211148 Protein biopolymer markers indicative of age matched control |
| 09/21/2006 | US20060211147 Protein biopolymer markers indicative of age matched control |
| 09/21/2006 | US20060211145 Diagnostic for insulin resistance |
| 09/21/2006 | US20060211144 Protein biopolymer markers indicative of age matched control |
| 09/21/2006 | US20060211143 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211142 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211141 Protein biopolymer markers predictive of insulin resistance |
| 09/21/2006 | US20060211140 Protein biopolymer markers predictive of insulin resistance |
| 09/21/2006 | US20060211139 Protein biopolymer markers predictive of insulin resistance |
| 09/21/2006 | US20060211138 Protein biopolymer markers predictive of insulin resistance |
| 09/21/2006 | US20060211113 Method and system for introducing a gene into a human stem cell |
| 09/21/2006 | US20060211107 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 09/21/2006 | US20060211091 MAGE-A3 peptides presented by HLA class II molecules |
| 09/21/2006 | US20060211090 Human cDNAs and proteins and uses thereof |
| 09/21/2006 | US20060211088 Method for generating variable domain sequences of heavy chain antibodies |
| 09/21/2006 | US20060211062 Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies |
| 09/21/2006 | US20060211058 Diagnosis and treatment of malignant neoplasms |
| 09/21/2006 | US20060211056 Leishmania antigens suitable for a diagnostic kit of Leishmania |
| 09/21/2006 | US20060211054 Using multi-immunoglobulin screening to preferentially discriminate between active (non-reduced) human parathyroid hormone and reduced parathyroid hormone in physiological sample; oxidative stress and dialysis |
| 09/21/2006 | US20060211053 Selecting therapeutic human monoclonal antibodies for disease-specific libraries |
| 09/21/2006 | US20060211052 Screening antibodies using an optical fiber array device capable of simultaneously performing multiple functional assays |
| 09/21/2006 | US20060211051 Methods and reagents for preparing and using immunological agents specific for p-glycoprotein |
| 09/21/2006 | US20060211049 Estrogen related receptor, ERRalpha, a regulator of bone formation |
| 09/21/2006 | US20060211033 Novel gene |
| 09/21/2006 | US20060211031 Novel proteins and nucleic acids encoding same |
| 09/21/2006 | US20060210629 Zinc-containing sustained-release composition, its preparation, and method for producing the same |
| 09/21/2006 | US20060210587 Virus-like particles for the induction of autoantibodies |
| 09/21/2006 | US20060210586 Recombination bcg vaccine |
| 09/21/2006 | US20060210577 isolated nucleic acid molecule encoding polypeptide as antitumor biodrugs; monoclonal antibody; modulation of chemokine, cytokine expression; transfected host cell; anticarcinogenic agents |
| 09/21/2006 | US20060210575 Cytotoxic protein and utilization thereof |
| 09/21/2006 | US20060210574 Administering immunoglobulins; determination titration of antibodies |
| 09/21/2006 | US20060210573 Containing one or more epitopes recognized by and binding to a BAT monoclonal antibody; diagnosing and treating cancer; cancer vaccines; monoclonal, polyclonal, recombinant, synthetic intact antibody and Fv, F(ab'), F(ab')2 and single chain antibody fragments; polynucleotides |
| 09/21/2006 | US20060210571 Engineering antibodies that bind irreversibly |
| 09/21/2006 | US20060210570 Drug screening; serine protease inhibitors; modulators of HAI-1/1B inhibition of prostasin |
| 09/21/2006 | US20060210569 cell growth inhibitors for pancreatic cancer |
| 09/21/2006 | US20060210567 Antibodies against pd-1 and uses therefor |
| 09/21/2006 | US20060210565 Antagonists of HMG1 for treating inflammatory conditions |
| 09/21/2006 | US20060210564 Novel diabody-type bispecific antibody |
| 09/21/2006 | US20060210563 Administration of anti-cytokine f(ab')2 antibody fragments |
| 09/21/2006 | US20060210561 Dosages for treatment with anti-EGFR antibodies |
| 09/21/2006 | US20060210560 TNF receptor action modulaton |
| 09/21/2006 | US20060210559 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 09/21/2006 | US20060210556 Novel composition and methods for the treatment of immune disorders |
| 09/21/2006 | US20060210554 Detection of cholesterol ozonation products |
| 09/21/2006 | US20060210475 Humanized L243 antibodies |
| 09/21/2006 | US20060210474 Customization of cancer therapy by adminstering modifying antibodies from antigens expressed from cancerous tissue which are cytotoxic to cancer cells while non-toxic to non-cancerous cells; monoclonal antibody antigen binding fragment having identifying characteristics to a cloned deposit |
| 09/21/2006 | US20060210473 VEGF-conjugate combined methods for tumor vasculature targeting and tumor treatment |
| 09/21/2006 | US20060210452 Very large scale immobilized polymer synthesis |